The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor
US Patent 07291736 Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligandsUS Patent 7291736 Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands
Infobox
Patent Number
072917360
Patent Number
72917360
Edits on 19 May, 2023
"Remove website redirecting to Patent Public Search front page"